Biodesix
I have always stayed away from small cap Biotech stocks. Mainly because it’s hard and your money is depending on things like clinical tests and medical trials being successful. Much different than a business establishing new products and increasing profit margin.
But Biodesix is an interesting one. They specialize in blood based testing for lung disease and lung cancer.
Since they cut shares almost a year ago from 156 mil to 8 mil, the stock is reaching new highs. Revenue is up 34% YOY along with expanding gross margin at 82%. Not bad.
